Li C, Ostermann T, Hardt M, Ldtke R, Broecker-Preuss M, Dobos G, Michalsen A: Metabolic and psychological response to 7-day fasting in obese patients with and without metabolic syndrome
Mens Cardiovascular Risk Profile Several factors create elevated cardiovascular risk in men: Earlier onset: Men develop heart disease approximately 10 years earlier than women on average
GLP-1 Medications GLP-1 (Glucagon-like peptide-1) medications are a type of injectable medication used for the treatment of obesity
START YOUR WEIGHT-LOSS WELLNESS JOURNEY TODAY Real solutions for health, confidence, and balance
Table of Contents Understanding GLP-1 Therapy in Type 1 Diabetes Potential Benefits and Clinical Outcomes Risks, Safety Concerns, and Limitations Patient Selection and Practical Considerations Understanding GLP-1 Therapy in Type 1 Diabetes GLP-1 receptor agonists are well established in type 2 diabetes, yet their role in type 1 diabetes remains off-label
The novel finding of the present study is that l-Carnitine protects RTCs from PFOS-mediated apoptosis by inhibiting the induction of ROS, pERK1/2, and IRE1 and then causing autophagy activation